Geron Explains Delay in Trial
At last, for the first time, Geron offers an explanation for the FDA-imposed hold on its highly publicized human embryonic stem cell clinical trial.
August 27, 2009
At last, for the first time, Geron offers an explanation for the FDA-imposed hold on its highly publicized human embryonic stem cell clinical trial.
Doctors in Houston use autologous adult stem cell therapy to treat heart failure in an FDA-approved clinical trial.
Russia’s Human Stem Cell Institute has announced that it is seeking funding from investors in what promises to be Russia’s first initial public offering in over a year.
Prosecutors in South Korea have recommended a four-year prison term for Hwang Woo-suk, whose fraudulent stem cell reports caused an international scandal.
The Olympic medalist Shannon Miller has signed a marketing endorsement partnership with StemCyte, one of the world’s leading cord blood banks.
The company RNL Biostar has announced the opening of a new adult stem cell R&D facility in Germantown, Maryland.